Who Paid My Doc
AFX2 Bifurcated Endograft System
Device Cardiology/Vascular Diseases
PDI 00818009014399
General payments
$1,110,848
Research payments
$178,171
Through program year 2025, $1,110,848 in general payments and $178,171 in research payments were reported against AFX2 Bifurcated Endograft System (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $271,725 | 1,096 |
| 2024 | General | $102,438 | 613 |
| 2023 | General | $158,178 | 804 |
| 2023 | Research | $20,049 | 2 |
| 2022 | General | $238,860 | 952 |
| 2022 | Research | $79,884 | 92 |
| 2021 | General | $339,647 | 749 |
| 2021 | Research | $78,238 | 93 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,214 general · 187 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.